2,3-oxidosqualene-lanosterol cyclase inhibitors
US6964974B2 · kind B2 · utility
0Cited by
6References
90Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2001 |
| Grant date | Nov 15, 2005 |
| Priority date | — |
| Expiry date | Mar 31, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/96
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to piperidine derivatives useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.